Lead Product(s) : Trimebutine Maleate
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Korea United Pharm. Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Trimebutine Maleate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Nausea.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 15, 2013
Lead Product(s) : Trimebutine Maleate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Korea United Pharm. Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
